Greenrose Acquisition Corp. (GNRSW) Research

Greenrose Holding Company Inc., operating via its subsidiaries, specializes in the manufacturing and commercialization of cannabis products. Its core business functions include cultivating, processing, and packaging medicinal cannabis and its related derivative items. The organization was established in 2014 and maintains its corporate headquarters in Amityville, New York.

Market snapshot

Symbol
GNRSW
Price
$0.00
Day change
-99.67%
Market cap
$1.8K
P/E ratio
0.00x
52-week range
1.0E-6-1.0E-6
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Beleave Inc. (BLEVF)
  • EPIRUS Biopharmaceuticals, Inc. (EPRSQ)
  • Global WholeHealth Partners Corporation (GWHP)
  • Integrated Pharmaceuticals, Inc. (INTP)
  • MEDirect Latino, Inc. (MLTO)
  • Orchid Ventures, Inc. (ORVRF)
  • RxElite, Inc. (RXEI)
  • Signature Eyewear, Inc. (SEYE)

Recent insider activity

  • Wang Bernard — trade (131887 shares) on 2022-08-08
  • ROSE BENJAMIN — trade (0 shares) on 2022-08-05
  • Megale Thomas J — trade (0 shares) on 2022-06-07
  • Stegner Jeffrey — trade (0 shares) on 2021-12-22
  • Megale Thomas J — A-Award (22480 shares) on 2022-02-18

Open Greenrose Acquisition Corp. (GNRSW) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.